Most recently, it's been identified that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in identical regions as classical opioid receptors, it binds to a wide array of endogenous opioids. In contrast to most opioid receptors, this receptor functions as a scavenger https://enricov738kqe7.loginblogin.com/profile